126 related articles for article (PubMed ID: 36604246)
21. Oncologic Outcomes of Partial Nephrectomy for Stage T3a Renal Cell Cancer.
Shvero A; Nativ O; Abu-Ghanem Y; Zilberman D; Zaher B; Levitt M; Fridman E; Portnoy O; Ramon J; Dotan ZA
Clin Genitourin Cancer; 2018 Jun; 16(3):e613-e617. PubMed ID: 29174471
[TBL] [Abstract][Full Text] [Related]
22. Clinical impact of segmental renal vein invasion on recurrence in patients with clinical T1 renal cell carcinoma undergoing partial nephrectomy.
Yoshida T; Ohe C; Tsuzuki T; Sugi M; Kinoshita H; Tsuta K; Matsuda T
Int J Clin Oncol; 2020 Mar; 25(3):464-471. PubMed ID: 31531786
[TBL] [Abstract][Full Text] [Related]
23. Significance of Pathologic T3a Upstaging in Clinical T1 Renal Masses Undergoing Nephrectomy.
Ramaswamy K; Kheterpal E; Pham H; Mohan S; Stifelman M; Taneja S; Huang WC
Clin Genitourin Cancer; 2015 Aug; 13(4):344-349. PubMed ID: 25680295
[TBL] [Abstract][Full Text] [Related]
24. Prognostic significance of preoperative and follow-up neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in patients with non-metastatic clear cell renal cell carcinoma.
Kim TW; Lee JH; Shim KH; Choo SH; Choi JB; Ahn HS; Kim SJ; Kim SI
Investig Clin Urol; 2019 Jan; 60(1):14-20. PubMed ID: 30637356
[TBL] [Abstract][Full Text] [Related]
25. Partial nephrectomy versus radical nephrectomy for non-metastatic pathological T3a renal cell carcinoma: a multi-institutional comparative analysis.
Oh JJ; Byun SS; Lee SE; Hong SK; Lee ES; Kim HH; Kwak C; Ku JH; Jeong CW; Kim YJ; Kang SH; Hong SH
Int J Urol; 2014 Apr; 21(4):352-7. PubMed ID: 24118633
[TBL] [Abstract][Full Text] [Related]
26. Pathological upstaging of clinical T1 renal cell carcinoma: an analysis of 115,835 patients from National Cancer Data Base, 2004-2013.
Ghanie A; Formica MK; Wang D; Bratslavsky G; Stewart T
Int Urol Nephrol; 2018 Feb; 50(2):237-245. PubMed ID: 29247309
[TBL] [Abstract][Full Text] [Related]
27. The impact of neutrophil-to-lymphocyte, platelet-to-lymphocyte and haemoglobin-to-platelet ratio on localised renal cell carcinoma oncologic outcomes.
Albisinni S; Pretot D; Al Hajj Obeid W; Aoun F; Quackels T; Peltier A; Roumeguère T
Prog Urol; 2019; 29(8-9):423-431. PubMed ID: 31196826
[TBL] [Abstract][Full Text] [Related]
28. De Ritis ratio (aspartate transaminase/alanine transaminase ratio) as a significant prognostic factor after surgical treatment in patients with clear-cell localized renal cell carcinoma: a propensity score-matched study.
Lee H; Lee SE; Byun SS; Kim HH; Kwak C; Hong SK
BJU Int; 2017 Feb; 119(2):261-267. PubMed ID: 27226065
[TBL] [Abstract][Full Text] [Related]
29. Outcomes and predictors of clinical T1 to pathological T3a tumor up-staging after robotic partial nephrectomy: a multi-institutional analysis.
Gorin MA; Ball MW; Pierorazio PM; Tanagho YS; Bhayani SB; Kaouk JH; Rogers CG; Stifelman MD; Khalifeh A; Kumar R; Sivarajan G; Allaf ME
J Urol; 2013 Nov; 190(5):1907-11. PubMed ID: 23764083
[TBL] [Abstract][Full Text] [Related]
30. The critical impact of tumor size in predicting cancer special survival for T3aM0M0 renal cell carcinoma: A proposal of an alternative T3aN0M0 stage.
Li L; Shi L; Zhang J; Fan Y; Li Q
Cancer Med; 2021 Jan; 10(2):605-614. PubMed ID: 33280246
[TBL] [Abstract][Full Text] [Related]
31. Impact of radiological morphology of clinical T1 renal cell carcinoma on the prediction of upstaging to pathological T3.
Teishima J; Hayashi T; Kitano H; Sadahide K; Sekino Y; Goto K; Inoue S; Honda Y; Sentani K; Awai K; Yasui W; Matsubara A
Jpn J Clin Oncol; 2020 Apr; 50(4):473-478. PubMed ID: 32100866
[TBL] [Abstract][Full Text] [Related]
32. The effect of AST/ALT (De Ritis) ratio on survival and its relation to tumor histopathological variables in patients with localized renal cell carcinoma.
Canat L; Ataly HA; Agalarov S; Alkan I; Altunrende F
Int Braz J Urol; 2018; 44(2):288-295. PubMed ID: 29211398
[TBL] [Abstract][Full Text] [Related]
33. Clinical Significance of Preoperative Neutrophil - to - Lymphocyte Ratio in Renal Cell Carcinoma.
Otunctemur A; Dursun M; Besiroglu H; Ozer K; Horsanali O; Ozbek E
Int Braz J Urol; 2016; 42(4):678-84. PubMed ID: 27564277
[TBL] [Abstract][Full Text] [Related]
34. Prognostic Significance of Inflammation-associated Blood Cell Markers in Nonmetastatic Clear Cell Renal Cell Carcinoma.
Lee A; Lee HJ; Huang HH; Tay KJ; Lee LS; Sim SPA; Ho SSH; Yuen SPJ; Chen K
Clin Genitourin Cancer; 2020 Aug; 18(4):304-313. PubMed ID: 31892491
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of Preoperative Aspartate Transaminase/Alanine Transaminase Ratio as an Independent Predictive Biomarker in Patients With Metastatic Renal Cell Carcinoma Undergoing Cytoreductive Nephrectomy: A Propensity Score Matching Study.
Ishihara H; Kondo T; Yoshida K; Omae K; Takagi T; Iizuka J; Tanabe K
Clin Genitourin Cancer; 2017 Oct; 15(5):598-604. PubMed ID: 28495053
[TBL] [Abstract][Full Text] [Related]
36. Prognostic significance of subclassifying stage pT3a renal tumors with fat invasion: a retrospective study of 99 patients.
Xu X; Zhu D
J Int Med Res; 2021 Aug; 49(8):3000605211033178. PubMed ID: 34382464
[TBL] [Abstract][Full Text] [Related]
37. Survival Analysis of Pathological T3a Upstaging in Clinical T1 Renal Cell Carcinoma.
Lai GS; Li JR; Wang SS; Chen CS; Yang CK; Hung SC; Cheng CL; Ou YC; Chiu KY
In Vivo; 2020; 34(2):799-805. PubMed ID: 32111787
[TBL] [Abstract][Full Text] [Related]
38. Risk Factors and Oncologic Outcomes for Clinical T1 Renal Cell Carcinoma Upstaging to Pathological T3a and The Construction of Predictive Model: A Retrospective Study.
Wang H; Wang K; Liu C; Wang G; Liu Y; Li G
Urol J; 2023 May; 20(3):148-156. PubMed ID: 36382432
[TBL] [Abstract][Full Text] [Related]
39. High R.E.N.A.L. Nephrometry scores are associated with pathologic upstaging of clinical T1 renal-cell carcinomas in radical nephrectomy specimens: implications for nephron-sparing surgery.
Tay MH; Thamboo TP; Wu FM; Zhaojin C; Choo TB; Ramaan L; Tiong HY
J Endourol; 2014 Sep; 28(9):1138-42. PubMed ID: 24810993
[TBL] [Abstract][Full Text] [Related]
40. Pre-treatment Delta Neutrophil Index as a Predictive Factor in Renal Cell Carcinoma.
Barut O; Demirkol MK; Kucukdurmaz F; Sahinkanat T; Resim S
J Coll Physicians Surg Pak; 2021 Feb; 31(2):156-161. PubMed ID: 33645181
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
